You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 106 No. 3, March 1988 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  LABORATORY SCIENCES
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (21)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Aqueous Humor Penetration of Ciprofloxacin in the Human Eye

Athanasios Th. Skoutelis, MD; Sotiris P. Gartaganis, MD; Costas J. Chrysanthopoulos, MD; Dieter Beermann, PhD; Christos Papachristou, MD; Harry P. Bassaris, MD

Arch Ophthalmol. 1988;106(3):404-405.


Abstract



• Two doses of ciprofloxacin were administered intravenously, 200 mg every 12 hours, to 25 patients undergoing cataract surgery. Plasma and aqueous humor were obtained at 1, 3, 5, 7, and 9 hours after the administration of the second dose of the drug. Peak intraocular concentrations (mean ± SD), 0.21 ±0.1 mg/L, were detected at one hour following ciprofloxacin administration. A time-dependent decrease of the penetration was observed, and by nine hours after the administration, ciprofloxacin levels were 0.05 mg/L. These results illustrate that ciprofloxacin may be an effective antimicrobial agent for prophylactic use in ophthalmologic surgery and also for the treatment of intraocular infections due to susceptible organisms.



Author Affiliations



From the Department of Medicine, Section of Infectious Diseases (Drs Skoutelis, Chrysanthopoulos, and Bassaris), and the Department of Ophthalmology (Dr Gartaganis), University of Patras (Greece) School of Medicine; and the Bayer AG, Wuppertal, West Germany (Drs Beermann and Papachristou).


Footnotes



Accepted for publication Oct 16, 1987.

Reprint requests to Department of Medicine, Agios Andreas Hospital, University of Patras, School of Medicine, Patras, Greece 26110 (Dr Bassaris).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Intraocular Safety of Ciprofloxacin
Stevens et al.
Arch Ophthalmol 1991;109:1737-1743.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.